Skip to main content
. 2019 Jun 24;38:276. doi: 10.1186/s13046-019-1261-5

Fig. 1.

Fig. 1

E2A expression correlates with progression-free survival of colorectal cancer. a E2A expression (upper panel) and Lgr5 expression (lower panel) in representative immunohistochemistry images. 200×. b Progression-free survival of patients with high and low E2A expression (P < 0.05). c Progression-free survival of patients with respective E2A and Lgr5 expression (P < 0.05)